Bifogade filer
Lumito attends the Digital Pathology & AI Congress in London
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Lumito via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2023-11-08 08:30:00
On December 7–8, Lumito will exhibit with a booth at the annual Digital Pathology & AI Congress in London. The presence is part of the company's branding work within the company's primary target group ahead of the upcoming launch of SCIZYS.
- It is important for us to build trust around our brand and product. We work to make ourselves visible early in the customer's buying journey to position our place in the minds of our primary target group. We exhibited at the Digital Pathology & AI Congress for the first time last year and see great value in returning this year to continue building on these relationships, comments CEO Mattias Lundin, who will attend with three colleagues in Sales & Marketing.
Lumito's SCIZYS product consists of a scanner and UCNP reagents (Upconverting Nano Particles staining liquids). According to the latest updated schedule, the assessment is to be completed, and CE mark SCIZYS in the first months of 2024.